Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment of Metastatic Urothelial Carcinoma: Frontline Chemo, IO in 1st Line and 2nd Line Setting, Enfortumab Vedotin in Post IO Setting & Erdafitinib for Patients With FGFR Alterations
Login to view comments.
Click here to Login
Updates in Oncology